Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 0.73 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.73 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.73 |
| ▸ | POLB | P06746 | 2/20 | 0.73 |
| ▸ | HPGD | P15428 | 1/20 | 0.73 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.71 |
| ▸ | NPC1 | O15118 | 9/20 | 0.70 |
| ▸ | RAB9A | P51151 | 9/20 | 0.70 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.70 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.70 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.69 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.69 |
| ▸ | SMO | Q99835 | 1/20 | 0.69 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.68 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.68 |
| ▸ | MAPT | P10636 | 1/20 | 0.67 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.67 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.65 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.65 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Iodide SCHEMBL30758572 | 0.98 | MEN1 (0.71) | MEN1KMT2AALDH1A1POLBHPGD | |
| SCHEMBL11550249 | 0.94 | MEN1 (0.68) | MEN1KMT2AALDH1A1POLBHPGD | |
| SCHEMBL2117869 | 0.92 | PTPN1 (0.71) | MEN1KMT2AALDH1A1POLBHPGD | |
| SCHEMBL9767723 | 0.90 | NPC1 (0.76) | MEN1KMT2APOLBPTPN1NPC1 | |
| SCHEMBL611657 | 0.90 | NPC1 (0.76) | MEN1KMT2APOLBPTPN1NPC1 | |
| SCHEMBL10939703 | 0.90 | NPC1 (0.76) | MEN1KMT2APOLBPTPN1NPC1 | |
| SCHEMBL126415 | 0.89 | PTPN1 (0.87) | MEN1KMT2APOLBPTPN1NPC1 | |
| SCHEMBL19501649 | 0.89 | SIRT1 (0.77) | MEN1KMT2AALDH1A1POLBHPGD | |
| SCHEMBL14715824 | 0.87 | NPC1 (0.88) | MEN1KMT2APOLBHPGDPTPN1 | |
| SCHEMBL18103163 | 0.87 | NPC1 (0.88) | MEN1KMT2APOLBHPGDPTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109232411-A | A method of preparing boscalid | 广东广康生化科技股份有限公司 | 2019-01-18 | — | — | CN | claimed |
| EP-1129075-A1 | N-ARYL(THIO)ANTHRANILIC ACID AMIDE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS VEGF RECEPTOR TYROSINE KINASE INHIBITORS | Novartis AG (CH) | 2001-09-05 | — | — | EP | claimed |
| WO-2000027820-A1 | N-ARYL(THIO)ANTHRANILIC ACID AMIDE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS VEGF RECEPTOR TYROSINE KINASE INHIBITORS | NOVARTIS AG (CH) | 2000-05-18 | — | — | WO | claimed |
| EP-0273444-A2 | Use of carboxamide compounds for the preparation of a medicament for treating hyperlipidemia | OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) | 1988-07-06 | — | — | EP | claimed |
| US-20260125340-A1 | METHOD FOR PREPARING AMIDES FROM ESTERS | BASF SE (DE) | 2026-05-07 | — | — | US | disclosed |
| EP-4598900-A1 | METHOD FOR PREPARING AMIDES FROM ESTERS | BASF SE (DE) | 2025-08-13 | — | — | EP | disclosed |
| CN-119998260-A | Process for preparing amides from esters | 巴斯夫欧洲公司 | 2025-05-13 | — | — | CN | disclosed |
| CN-118048636-B | Electrocatalytic synthesis method for N-aryl amide | 平顶山学院 | 2024-09-13 | — | — | CN | disclosed |
| CN-118420484-B | Method for preparing amide compounds | 四川大学 | 2024-08-30 | — | — | CN | disclosed |
| CN-118420484-A | Method for preparing amide compounds | 四川大学 | 2024-08-02 | — | — | CN | disclosed |
| CN-118048636-A | Electrocatalytic synthesis method for N-aryl amide | 平顶山学院 | 2024-05-17 | — | — | CN | disclosed |
| WO-2024074641-A1 | METHOD FOR PREPARING AMIDES FROM ESTERS | BASF SE (DE) | 2024-04-11 | — | — | WO | disclosed |
| US-5514740-A | SHEET OR FILM HAVING CUPRIC SULFIDE DISPERSED THEREIN | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1996-05-07 | — | — | US | disclosed |
| EP-0273444-A2 | Use of carboxamide compounds for the preparation of a medicament for treating hyperlipidemia | OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) | 1988-07-06 | — | — | EP | disclosed |
| US-4499167-A | Photoconductive compositions comprising an organic photoconductor and an amide compound and electro-photographic light-sensitive materials using the compositions | FUJI PHOTO FILM CO., LTD. (JP) | 1985-02-12 | — | — | US | disclosed |
| US-4487781-A | HEAT RESISTANCE; PHOTOSTABILITY | SANKYO COMPANY LIMITED (JP) | 1984-12-11 | — | — | US | disclosed |
| EP-0057058-B1 | A METHOD OF PRESERVING ORGANIC MATERIALS FROM FUNGAL ATTACK AND A COMPOSITION FOR USE IN SUCH A METHOD | SANKYO COMPANY LIMITED (JP) | 1984-04-11 | — | — | EP | disclosed |
| US-4421766-A | 3-HALO-2,3-DIIODOACRYLIC ACID OR ESTER | SANKYO CO., LTD. (JP) | 1983-12-20 | — | — | US | disclosed |
| EP-0057058-A1 | A method of preserving organic materials from fungal attack and a composition for use in such a method | SANKYO COMPANY LIMITED (JP) | 1982-08-04 | — | — | EP | disclosed |
| US-4093648-A | ANTIANAPHYLACTIC AGENTS | RECORDATI S.A. CHEMICAL AND PHARMACEUTICAL COMPANY (CH) | 1978-06-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260125340-A1 | METHOD FOR PREPARING AMIDES FROM ESTERS | CBR1, CBR3, SCO2 | MEN1 2007/4885KMT2A 1928/4885ALDH1A1 117/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.